486 related articles for article (PubMed ID: 14508331)
1. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Makriyannis A; Hohmann AG
Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
[TBL] [Abstract][Full Text] [Related]
3. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
[TBL] [Abstract][Full Text] [Related]
4. CB2 cannabinoid receptor-mediated peripheral antinociception.
Malan PT; Ibrahim MM; Deng H; Liu Q; Mata HP; Vanderah T; Porreca F; Makriyannis A
Pain; 2001 Sep; 93(3):239-245. PubMed ID: 11514083
[TBL] [Abstract][Full Text] [Related]
5. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.
Nackley AG; Zvonok AM; Makriyannis A; Hohmann AG
J Neurophysiol; 2004 Dec; 92(6):3562-74. PubMed ID: 15317842
[TBL] [Abstract][Full Text] [Related]
6. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.
Ibrahim MM; Deng H; Zvonok A; Cockayne DA; Kwan J; Mata HP; Vanderah TW; Lai J; Porreca F; Makriyannis A; Malan TP
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10529-33. PubMed ID: 12917492
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin.
Hohmann AG; Farthing JN; Zvonok AM; Makriyannis A
J Pharmacol Exp Ther; 2004 Feb; 308(2):446-53. PubMed ID: 14610224
[TBL] [Abstract][Full Text] [Related]
8. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
9. CB2 cannabinoid receptor mediation of antinociception.
Ibrahim MM; Rude ML; Stagg NJ; Mata HP; Lai J; Vanderah TW; Porreca F; Buckley NE; Makriyannis A; Malan TP
Pain; 2006 May; 122(1-2):36-42. PubMed ID: 16563625
[TBL] [Abstract][Full Text] [Related]
10. Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors.
Su TF; Zhao YQ; Zhang LH; Peng M; Wu CH; Pei L; Tian B; Zhang J; Shi J; Pan HL; Li M
Eur J Pain; 2012 May; 16(5):624-35. PubMed ID: 22337285
[TBL] [Abstract][Full Text] [Related]
11. Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain.
Guenther KG; Xu Z; Romero J; Hillard CJ; Mackie K; Hohmann AG
Neuropharmacology; 2023 Oct; 237():109601. PubMed ID: 37286073
[TBL] [Abstract][Full Text] [Related]
12. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
Ibrahim MM; Porreca F; Lai J; Albrecht PJ; Rice FL; Khodorova A; Davar G; Makriyannis A; Vanderah TW; Mata HP; Malan TP
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3093-8. PubMed ID: 15705714
[TBL] [Abstract][Full Text] [Related]
13. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G
Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.
Curto-Reyes V; Boto T; Hidalgo A; Menéndez L; Baamonde A
Eur J Pharmacol; 2011 Oct; 668(1-2):184-9. PubMed ID: 21771590
[TBL] [Abstract][Full Text] [Related]
16. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
[TBL] [Abstract][Full Text] [Related]
17. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI
Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339
[TBL] [Abstract][Full Text] [Related]
18. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
Stepanović-Petrović RM; Micov AM; Tomić MA; Ugrešić ND
Anesth Analg; 2012 Dec; 115(6):1457-66. PubMed ID: 23144430
[TBL] [Abstract][Full Text] [Related]
19. CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.
Khasabova IA; Gielissen J; Chandiramani A; Harding-Rose C; Odeh DA; Simone DA; Seybold VS
Behav Pharmacol; 2011 Sep; 22(5-6):607-16. PubMed ID: 21610490
[TBL] [Abstract][Full Text] [Related]
20. Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y
Niu J; Huang D; Zhou R; Yue M; Xu T; Yang J; He L; Tian H; Liu X; Zeng J
J Neuroinflammation; 2017 Sep; 14(1):185. PubMed ID: 28899427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
